Skip to main content

Table 3 Complete blood count data for 22 men and women assigned to Glavonoid™ or placebo for eight weeks.

From: A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity

Variable Glavonoid™ Pre
(n = 11)
Glavonoid™ Post
(n = 11)
Placebo
Pre
(n = 11)
Placebo
Post
(n = 11)
WBC (103· μL-1) 5.8 ± 0.4 5.8 ± 0.4 6.6 ± 0.5 6.0 ± 0.6
RBC (106· μL-1) 4.5 ± 0.1 4.4 ± 0.1 4.4 ± 0.1 4.5 ± 0.1
Hemoglobin (g·dL-1) 13.8 ± 0.4 13.6 ± 0.3 13.5 ± 0.5 14.0 ± 0.5
Hematocrit (%) 39.7 ± 1.0 40.1 ± 1.0 39.2 ± 1.4 40.9 ± 1.4
MCV (fL) 88.7 ± 1.1 90.6 ± 1.4 90.1 ± 1.1 90.9 ± 1.6
MCH (pg) 30.7 ± 0.4 30.7 ± 0.4 31.0 ± 0.6 31.1 ± 0.5
MCHC (g·dL-1) 34.7 ± 0.2 34.0 ± 0.2 34.5 ± 0.3 34.2 ± 0.2
RDW (%) 13.4 ± 0.2 13.5 ± 0.3 13.8 ± 0.4 13.5 ± 0.4
Platelets (103· μL-1) 201.7 ± 14.2 200.9 ± 14.8 212.6 ± 20.0 215.5 ± 18.8
Neutrophils (%) 55.4 ± 1.9 58.3 ± 4.1 52.2 ± 3.0 51.2 ± 3.3
Lymphocytes (%) 33.5 ± 2.0 31.2 ± 3.6 37.4 ± 2.9 37.6 ± 3.0
Monocytes (%) 7.5 ± 0.5 6.9 ± 0.6 6.9 ± 0.8 7.3 ± 0.7
Eosinophils (%) 3.0 ± 0.6 3.1 ± 0.5 3.3 ± 0.8 3.4 ± 0.7
Basophils (%) 0.6 ± 0.2 0.5 ± 0.2 0.2 ± 0.1 0.5 ± 0.2
  1. Values are mean ± SEM.
  2. No condition × pre/post intervention interaction effects noted (p > 0.05).
  3. No condition effects noted (p > 0.05).
  4. No pre/post intervention effects noted (p > 0.05).